Cargando…

Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays

Trace amine-associated receptor 1 (TAAR1) is an attractive target for the design of innovative drugs to be applied in diverse pharmacological settings. Due to a non-negligible structural similarity with endogenous ligands, most of the agonists developed so far resulted in being affected by a low sel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cichero, Elena, Francesconi, Valeria, Casini, Beatrice, Casale, Monica, Kanov, Evgeny, Gerasimov, Andrey S., Sukhanov, Ilya, Savchenko, Artem, Espinoza, Stefano, Gainetdinov, Raul R., Tonelli, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674299/ https://www.ncbi.nlm.nih.gov/pubmed/38004497 http://dx.doi.org/10.3390/ph16111632

Ejemplares similares

Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies
por: Francesconi, Valeria, et al.
Publicado: (2020)

Discovery of Novel Trace Amine-Associated Receptor 5 (TAAR5) Antagonists Using a Deep Convolutional Neural Network
por: Bon, Carlotta, et al.
Publicado: (2022)

Discovery of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 2-(5-(4′-Chloro-[1,1′-biphenyl]-4-yl)-4H-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the Treatment of Psychotic Disorders
por: Krasavin, Mikhail, et al.
Publicado: (2022)

Behavioral Effects of a Potential Novel TAAR1 Antagonist
por: Lam, Vincent M., et al.
Publicado: (2018)

The Expression of Trace Amine-Associated Receptors (TAARs) in Breast Cancer Is Coincident with the Expression of Neuroactive Ligand–Receptor Systems and Depends on Tumor Intrinsic Subtype
por: Vaganova, Anastasia N., et al.
Publicado: (2023)

Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397
por: Espinoza, Stefano, et al.
Publicado: (2018)

Discovery and In Vivo Efficacy of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 4-(2-Aminoethyl)-N-(3,5-dimethylphenyl)piperidine-1-carboxamide Hydrochloride (AP163) for the Treatment of Psychotic Disorders
por: Krasavin, Mikhail, et al.
Publicado: (2022)

Search for Structural Basis of Interactions of Biogenic Amines with Human TAAR1 and TAAR6 Receptors
por: Glyakina, Anna V., et al.
Publicado: (2021)

Improved cognitive performance in trace amine-associated receptor 5 (TAAR5) knock-out mice
por: Maggi, Silvia, et al.
Publicado: (2022)

Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience
por: Savchenko, Artem, et al.
Publicado: (2023)

Pattern of TAAR5 Expression in the Human Brain Based on Transcriptome Datasets Analysis
por: Vaganova, Anastasia N., et al.
Publicado: (2021)

Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer’s Disease
por: Leo, Damiana, et al.
Publicado: (2022)

Gut Microbiota Alterations in Trace Amine-Associated Receptor 9 (TAAR9) Knockout Rats
por: Zhukov, Ilya S., et al.
Publicado: (2022)

Evaluation of Approach to a Conspecific and Blood Biochemical Parameters in TAAR1 Knockout Mice
por: Zhukov, Ilya S., et al.
Publicado: (2022)

Deregulation of Trace Amine-Associated Receptors (TAAR) Expression and Signaling Mode in Melanoma
por: Vaganova, Anastasia N., et al.
Publicado: (2022)

Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia
por: Heffernan, Michele L. R., et al.
Publicado: (2021)

Minor Changes in Erythrocyte Osmotic Fragility in Trace Amine-Associated Receptor 5 (TAAR5) Knockout Mice
por: Zhukov, Ilya S., et al.
Publicado: (2021)

Noradrenergic Modulation of Learned and Innate Behaviors in Dopamine Transporter Knockout Rats by Guanfacine
por: Volnova, Anna, et al.
Publicado: (2023)

Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders
por: Kuvarzin, Savelii R., et al.
Publicado: (2023)

Enhanced Aggression, Reduced Self-Grooming Behavior and Altered 5-HT Regulation in the Frontal Cortex in Mice Lacking Trace Amine-Associated Receptor 1 (TAAR1)
por: Zhukov, Ilya S., et al.
Publicado: (2022)

Guanfacine for the Treatment of Cognitive Disorders: A Century of Discoveries at Yale
por: Arnsten, Amy F.T., et al.
Publicado: (2012)

Structural and Functional Evolution of the Trace Amine-Associated Receptors TAAR3, TAAR4 and TAAR5 in Primates
por: Stäubert, Claudia, et al.
Publicado: (2010)

Inhibition of PDE10A in a New Rat Model of Severe Dopamine Depletion Suggests New Approach to Non-Dopamine Parkinson’s Disease Therapy
por: Sukhanov, Ilya, et al.
Publicado: (2022)

TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT(1A) receptor agonist SEP-363856
por: Saarinen, Marcus, et al.
Publicado: (2022)

Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine
por: Sukhanov, Ilya, et al.
Publicado: (2018)

Trace amine-associated receptors at the cross-road between innate olfaction of amines, emotions, and adult neurogenesis
por: Efimova, Evgeniya V., et al.
Publicado: (2021)

Correction To: TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT(1A) receptor agonist SEP- 363856
por: Saarinen, Marcus, et al.
Publicado: (2022)

Identification and characterization of cichlid TAAR genes and comparison with other teleost TAAR repertoires
por: Azzouzi, Naoual, et al.
Publicado: (2015)

Effects of alpha 2-adrenoceptor agonists dexmedetomidine and guanfacine on morphine analgesia and tolerance in rats
por: Gursoy, Sinan, et al.
Publicado: (2011)

Novel translational rat models of dopamine transporter deficiency
por: Leo, Damiana, et al.
Publicado: (2018)

Public Transcriptomic Data Meta-Analysis Demonstrates TAAR6 Expression in the Mental Disorder-Related Brain Areas in Human and Mouse Brain
por: Vaganova, Anastasia N., et al.
Publicado: (2022)

Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia
por: Achtyes, Eric D., et al.
Publicado: (2023)

Genetic Deletion of Trace-Amine Associated Receptor 9 (TAAR9) in Rats Leads to Decreased Blood Cholesterol Levels
por: Murtazina, Ramilya Z., et al.
Publicado: (2021)

Role of the trace amine associated receptor 5 (TAAR5) in the sensorimotor functions
por: Kalinina, D. S., et al.
Publicado: (2021)

Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies
por: Dedic, Nina, et al.
Publicado: (2021)

Analysis of Human TAAR8 and Murine Taar8b Mediated Signaling Pathways and Expression Profile
por: Mühlhaus, Jessica, et al.
Publicado: (2014)

Taare Zameen Par and dyslexic savants
por: Chakravarty, Ambar
Publicado: (2009)

Effect of TAAR1/5-HT(1A) agonist SEP-363856 on REM sleep in humans
por: Hopkins, Seth C., et al.
Publicado: (2021)

The Potential Antidepressant Action of Duloxetine Co-Administered with the TAAR1 Receptor Agonist SEP-363856 in Mice
por: Ren, Xia, et al.
Publicado: (2022)

Metabolite profiling of guanfacine in plasma and urine of healthy Japanese subjects after oral administration of guanfacine extended‐release tablets
por: Inoue, Yuji, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t0ebun4pdn0k922gjl5pgjd9dt